Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Gut|June 9, 2012
Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesionsAlbrecht Neesse, Anke Hahnenkamp, Heidi Griesmann, et al.
American Journal of Surgery|March 27, 2020
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3Elettra Merola, Massimo Falconi, Anja Rinke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Specialized DNA arrays for the differentiation of pancreatic tumorsMalte Buchholz, Hans A Kestler, Andrea Bauer, et al.
The Journal of Biological Chemistry|June 2, 2011
Disruption of a nuclear NFATc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acidShiv K Singh, Sandra Baumgart, Garima Singh, et al.
Gastroenterology|November 11, 2009
NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cellsAlexander Köenig, Thomas Linhart, Katrin Schlengemann, et al.
Plos One|December 13, 2017
Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasmsAlexander Koenig, Sebastian Krug, Daniela Mueller, et al.
Cancer Research|October 16, 2003
Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancerPatrick Michl, Claudia Barth, Malte Buchholz, et al.
Journal of Neuroendocrinology|October 28, 2022
High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intentElettra Merola, Aurel Perren, Anja Rinke, et al.
Gut|March 11, 2021
Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?Anja Rinke, Christoph J Auernhammer, Lisa Bodei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial)Christian Fottner, Leonidas Apostolidis, Sebastian Krug, et al.
Pageof 14